Eyenovia, a NASDAQ-listed digital eye care company, is taking a bold step into the crypto world. The company announced a $50 million private investment from institutional investors to create a cryptocurrency treasury focused on the HYPE token, native to the Hyperliquid blockchain.
With this move, Eyenovia became the first publicly traded U.S. company to hold HYPE tokens in its treasury. According to the official announcement, the company will also rebrand itself as Hyperion DeFi and change its ticker symbol from EYEN to HYPD.
As part of the investment deal, Eyenovia will issue convertible preferred stock and warrants. Depending on the conditions of the investors, the company may raise up to $150 million in case all warrants are exercised.
Eyenovia intends to purchase more than one million HYPE tokens, which would make it one of the largest validators on the Hyperliquid blockchain. The company will also deposit these tokens to generate yields and will collateralize the assets with Anchorage Digital.
CEO Michael Rowe said this shift is part of a strategy to diversify and support long-term growth. New Chief Investment Officer Hyunsu Jung praised HYPE as a highly advanced digital asset and highlighted Hyperliquid’s rapid revenue growth.
Eyenovia is entering the crypto market, but it will not give up the eye care business. The company is working on the next generation Optejet dispenser with an aim to have it registered by FDA in September 2025.
HYPE is trading at Nearly at its all-time high of $44.75, it was trading at $40.82. Eyenovia anticipates the transaction to be completed on June 20, 2025. It is a special combination of biotech innovation and decentralized finance.
